euromuscular function monitoring to assess patient recovery from muscles relaxants.

Not Applicable

• Conditions: Residual Neuromuscular Blockade; Medication (Neuromuscular Blockade) Monitoring; Respiratory Failure; Aspiration of Gastric Contents; Anaesthesiology - Anaesthetics

• Registration Number: ACTRN12618002039268
• Lead Sponsor: The Sydney Adventist Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-12-20
• Last Update Posted: 14 January 2019

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 35

Inclusion Criteria

Inclusion criteria - 18 years of age, receive neuromuscular blocking agent.

Exclusion Criteria

Exclusion criteria – previous procedures or pre-existing condition where TOF ratio may not be measure accurately, allergy to adhesive gel electrodes, difficult access to the hand, neuromuscular disease.

Study & Design

• Study Type: Interventional
• Study Design: Not specified